Systematic Pan-Cancer Analysis Identifies TREM2 as an Immunological and Prognostic Biomarker

Systematic Pan-Cancer Analysis Identifies TREM2 as an Immunological and Prognostic Biomarker

Triggering receptor expressed on myeloid cells-2 (TREM2) is a transmembrane receptor of the immunoglobulin superfamily and a crucial signaling hub for multiple pathological pathways that mediate immunity. Although increasing evidence supports a vital role for TREM2 in tumorigenesis of some cancers,...

Full description

Bibliographic Details
Main Authors: Xin Cheng, Xiaowei Wang, Kechao Nie, Lin Cheng, Zheyu Zhang, Yang Hu, Weijun Peng
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-02-01
Series:Frontiers in Immunology
Subjects:
TREM2
pan-cancer
prognosis
immune infiltration
TMB
MSI
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2021.646523/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2021.646523/full

Similar Items